In conclusion, this scoping review highlights the limited but notable evidence supporting BDNF as a potential marker for the effectiveness of exercise/PA in managing symptoms such as fatigue, pain, depression, and sleep disturbances. Here, BDNF is linked to depressive symptom measurement.